Ali A, Rota L, Marshall K, Yao Y, Ji R, DeFilipp Z. Belumosudil achieves clinical response in chronic graft-versus-host disease with varying organ-specific response kinetics: an analysis from the phase II ROCKstar trial. haematol [Internet]. 2020Sep.10 [cited 2026Jul.29];. Available from: https://haematologica.org/article/view/14310